Initial lithium and valproate combination therapy in acute mania

Neuropsychobiology

Volumn 46, Issue SUPPL. 1, 2002, Pages 22-27

  Reischies, Friedel M ^a   Hartikainen, Jukka ^a   Berghöfer, Anne ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Acute mania; Combination therapy; Lithium; Valproate

Indexed keywords

CHLORPROMAZINE; DIAZEPAM; LITHIUM; NEUROLEPTIC AGENT; VALPROIC ACID;

ACUTE DISEASE; BIPOLAR MANIA; COMPARATIVE STUDY; CONFERENCE PAPER; DISEASE SEVERITY; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; EVALUATION; LATENT PERIOD; MANIA; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; REMISSION; RETROSPECTIVE STUDY; SEDATION; STATISTICAL SIGNIFICANCE;

ACUTE DISEASE; ADULT; AGED; ANTIMANIC AGENTS; BIPOLAR DISORDER; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LITHIUM; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VALPROIC ACID;

EID: 0036976115     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000068020     Document Type: Conference Paper

References (39)

1. Bauer M, Ahrens B: Bipolar disorder. A practical guide to drug treatment. CNS Drugs 1996;6:35-52.
2. Bobon D, Baumann U, Angst J, Helmchen H, Hippius H (eds): AMDP System in Pharmacopsychiatry. Basel, Karger, 1983.
3. Bowden CL, Brugger AM, Swann AC, Calabrese J: Efficacy of divalproex vs. lithium and placebo in the treatment of mania. JAMA 1994;271:918-924.
4. Bowden CL, Calabrese JR, McElroy SL, Gyulai L, Wassef A, Petty F, Pope HG, Chou JCY, Keck PE Jr, Rhodes LJ, Swann AC, Hirschfeld RMA, Wozniak PJ: A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Arch Gen Psychiatry 2000;57:481-489.
5. Bowden CL, Janicak PG, Orsulak P, Swann AC, Davis JM, Calabrese JR, Goodnick P, Small JG, Ruch AJ, Kimmel SE, Risch SC, Morris DD: Relation of serum valproate concentration to response in mania. Am J Psychiatry 1996;153:765-777.
6. Bowden CL: New concepts in mood stabilization: Evidence for the effectiveness of valproate and lamotrigine. Neuropsychopharmacology 1998;19:194-199.
7. Brotman MA, Fergus EL, Post RM, Leverich GS: High exposure to neuroleptics in bipolar patients: A retrospective review. J Clin Psychiatry 2000;61:68-72.
8. Calabrese JR, Markovitz PJ, Kimmel SE, Wagner SC: Spectrum of efficacy of valproate in 78 rapid-cycling bipolar patients. J Clin Psychopharmacol 1992;12:53-56.
9. Davis LL, Ryan W, Adinoff B, Petty F: Comprehensive review of the psychiatric uses of valproate. J Clin Psychiatry 2000;20(suppl 1):1S-17S.
10. Denicoff KD, Smith-Jackson EE, Bryan AL, Ali SO, Post RM: Valproate prophylaxis in a prospective clinical trial of refractory bipolar disorder. Am J Psychiatry 1997;154:1456-1458.
11. Dietmaier O, Laux G: Übersichtstabellen; in Riederer P, Laux G, Pöldinger W (eds): Neuropsychopharmaka. Neuroleptika. Wien, Springer, 1992, vol 4, pp 197-215.
12. Emrich HM, Dose M, von Zerssen D: The use of sodium valproate, carbamazepine and oxcarbazepine in patients with affective disorders. J Affect Dis 1985;8:243-250.
13. Freeman MP, Stoll AL: Mood stabilizer combinations: A review of safety and efficacy. Am J Psychiatry 1998;155:12-21.
14. Gebhardt R, Pietzcker A, Freudenthal K, Langer C: Die Bildung von Syndromen im AMP-System. Arch Psychiatr Nervenkr 1981;231:93-109.
15. Gitlin MJ, Swendsen J, Heller TL, Hammen C: Relapse and impairment in bipolar disorder. Am J Psychiatry 1995;152:1635-1640.
16. Grannemann GR, Schneck DW, Cavanaugh JH, Witt GF: Pharmacokinetic interactions and side effects resulting from concomitant administration of lithium and divalproex sodium. J Clin Psychiatry 1996;57:204-206.
17. Hunt N, Silverstone T: Tardive dyskinesia in bipolar affective disorder: A catchment area study. Int Clin Psychopharmacol 1991;6:45-50.
18. Keck PE Jr, McElroy SL, Bennett JA: Health-economic implications of the onset of action of antimanic agents. J Clin Psychiatry 1996;57(suppl13):13-18.
19. Keck PE Jr, McElroy SL, Tugrul KC, Bennett JA: Valproate oral loading in the treatment of acute mania. J Clin Psychiatry 1993;54:213-222.
20. Keck PR Jr, McElroy SL, Strakowski SM: Anticonvulsants and antipsychotics in the treatment of bipolar disorder. J Clin Psychiary 1998;58(suppl 6):74-81.
21. Keck PR Jr, Strakowski SM, Hawkins JM, Dunayevich E, Tugrul KC, Bennett JA, McElroy SL: A pilot study of rapid lithium administration in the treatment of acute mania. Bipolar Disord 2001;3:68-72.
22. Licht R: Drug treatment of mania: A critical review. Acta Psychiatr Scand 1998;97:387-397.
23. Maj M: The impact of lithium prophylaxis on the course of bipolar disorder: A review of the research evidence. Bipolar Disord 2000;2:93-101.
24. McElroy SL, Keck PE Jr, Pope HG Jr, Hudson JI: Valproate in the treatment of bipolar disorder: Literature review and clinical guidelines. J Clin Psychopharmacol 1992;12:42S-52S.
25. Mc Elroy SL, Keck PE Jr, Stanton SP, Tugrul KC, Bennett JA, Strakowski SM: A randomized comparison of divalproex oral loading versus haloperidol in the initial treatment of acute psychotic mania. J Clin Psychiatry 1996;57:142-146.
26. Mukherjee S, Rosen AM, Caracci G, Shukla S: Persistent tardive dyskinesia in bipolar patients. Arch Gen Psychiatry 1986;43:342-346.
27. Müller-Oerlinghausen B, Retzow A, Henn FA, Giedke H, Walden J, for the European Valproate Mania Study Group: Valproate as an adjunct to neuroleptic medication for the treatment of acute episodes of mania: A prospective, randomized, double-blind, placebo-controlled, multicenter study. J Clin Psychopharmacol 2000;20:195-203.
28. Niedermier JA, Nasrallah HA: Clinical correlates of response to valproate in geriatric inpatients. Ann Clin Psychiatry 1998;10:165-168.
29. Petty F, Rush AJ, Davis JM, Calabrese JR, Kimmel SE, Kramer GL, Small JG, Miller MJ, Swann, AE, Orsulak PJ, Blake ME, Bowden CL: Plasma GABA predicts acute response to divalproex in mania. Biol Psychiatry 1996;39:278-284.
30. Pope H G, McElroy SL, Keck PE, Hudson JI: Valproate in the treatment of acute mania. Arch Gen Psychiatry 1991;48:62-68.
31. Prien RF, Caffey EM, Klett CJ: A comparison of lithium carbonate and chlorpromazine in the treatment of acute mania. Arch Gen Psychiatry 1972;26:146-153.
32. Reetz-Kokott U, Müller-Oerlinghausen B: Hat sich die medikamentöse Behandlung der Manien im klinischen Alltag verändert? Retrospektive Analyse der Behandlungsmodalitäten und -ergebnisse in einer psychiatrischen Universitätsklinik. Nervenarzt 1996;67:229-234.
33. Schneider AL, Wilcox CS: Divalproate augmentation in lithium-resistant rapid cycling mania in four geriatric patients. J Affect Disord 1998;47:201-205.
34. Schou M: Perspectives on lithium treatment of bipolar disorder: Action, efficacy, effect on suicidal behavior. Bipolar Disord 1999;1:5-10.
35. Soarez JC: Recent advances in the treatment of bipolar mania, depression, mixed states, and rapid cycling. Int Clin Psychopharmacol 2000;15:183-196.
36. Solomon DA, Keitner GI, Ryan CE, Miller IW: Lithium plus valproate as maintenance polypharmacy for patients with bipolar I disorder: A review. J Clin Psychopharmacol 1998;18:38-49.
37. Tohen M, Grundy S: Management of acute mania. J Clin Psychiatry 1999;60(suppl 5):31-34.
38. Vestergaard P: Treatment and prevention of mania: A Scandinavian perspective. Neuropsychopharmacology 1992;7:249-259.
39. Walden J, Normann C, Langosch J, Berger M, Grunze H: Differential treatment of bipolar disorder with old and new antiepileptic drugs. Neuropsychobiology 1998;38:181-184.